Q4 2019 13F Combination Report, New Holdings, Stock Holdings
Signature - Title
John McCallion - EVP, CFO, and Head of MetLife Investment Management
Location
New York, NY
Holdings as of
December 31, 2019
Value $
$3.17M
Num holdings
2
Date filed
7/13/2023, 09:12 AM
Description
The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as
of the end of the calendar quarter for which the report is filed, and the total market value. The market value
column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in
accounts.
Our algorithm has found invalid data in this filing
Sym
Weight
Trade Impact
Company
Class
Shares Change
Activity
Value Change $
Value $
* Price $
Shares
Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Steven Goulart
EVP & Chief Investment Officer
Whippany, New Jersey
7/12/2023
This amendment adds new holdings entries of securities that were inadvertently omitted in the 13F Combination Report filed for this quarter, as amended by the 13F amendment filed on July 12, 2023. MetLife, Inc. is the parent holding company of certain institutional investment managers. For purposes of the reporting requirements under Section 13(f) of the Securities Exchange Act of 1934 (the Act), and the rules promulgated thereunder, MetLife, Inc. itself does not exercise, and therefore disclaims, investment discretion with respect to any Section 13(f) securities positions over which its investment operating subsidiaries exercise such discretion. To the extent, however, that MetLife Inc.'s ownership interest in such subsidiaries may nevertheless give rise to a Form 13F obligation on behalf of MetLife, Inc., the information required by Form 13F is reported herein on behalf of all such subsidiaries.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.